Source: Annual Congress 2007 - Exercise: measurements, techniques and paradigms



Rating:

Share or cite this content

Citations should be made in the following way:
H. Dressel, L. Filser, R. Fischer, D. de la Motte, W. Steinhaeusser, G. Praml, R. M. Huber, D. Nowak, R. A. Jörres (Munich, Würzburg, Germany). Lung diffusing capacity for nitric oxide and carbon monoxide: methodological issues and reproducibility in patients with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 1992

Member's Comments

No comment yet.

Related content which might interest you: Diffusing capacity of the lung for nitric oxide and carbon monoxide: Influence of alveolar volume Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Reference equations for pulmonary diffusing capacity of carbon monoxide and nitric oxide in adult Caucasians Source: Eur Respir J, 52 (1) 1500677; 10.1183/13993003.00677-2015 Year: 2018 Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in patients with cystic fibrosis Source: International Congress 2017 – Discussion of techniques and technologies in lung function Year: 2017 Diffusing capacity for nitric oxide and carbon monoxide in lung transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 A small amount of inhaled nitric oxide does not increase lung diffusing capacity Source: Eur Respir J 2006; 27: 1251-1257 Year: 2006 The value of diffusing capacity for nitric oxide and carbon monoxide in sickle cell disease Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Standardization of pulmonary diffusing capacity for nitric oxide Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring Year: 2017 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Bronchial blood flow is normal in COPD patients and is positevily correlated with exhaled nitric oxide and the diffusion of carbon monoxide Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Infections increase exhaled nitric oxide, but not carbon monoxide levels in lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 329s Year: 2003 Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Source: Eur Respir J 2002; 20: 92-99 Year: 2002 Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis Source: Eur Respir J, 50 (4) 1701008; 10.1183/13993003.01008-2017 Year: 2017 Airway acidification and exhaled nitric oxide in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003 Using a membrane oxygenator for simultaneous measurement of nitric oxide and carbon monoxide diffusing capacity Source: Eur Respir J 2003; 22: Suppl. 45, 86s Year: 2003 Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006